Read More 1 minute read Analyst Ratings Initiation News Scotiabank Initiates Coverage On NEXTracker with Sector Outperform Rating By Benzinga Newsdesk March 6, 7:37 AM Scotiabank analyst Tristan Richardson initiates coverage on NEXTracker (NASDAQ:NXT) with a Sector Outperform rating. NXT
Read More 1 minute read Analyst Ratings Initiation News Price Target Cantor Fitzgerald Initiates Coverage On Oncolytics Biotech with Overweight Rating, Announces Price Target of C$9 By Benzinga Newsdesk March 6, 7:21 AM Cantor Fitzgerald analyst Louise Chen initiates coverage on Oncolytics Biotech (TSX:ONC) with a Overweight rating and announces Price Target of C$9. TSX:ONC
Read More 1 minute read Analyst Ratings Initiation News Price Target Mizuho Initiates Coverage On NEXTracker with Buy Rating, Announces Price Target of $40 By Benzinga Newsdesk March 6, 6:58 AM Mizuho analyst Anthony Crowdell initiates coverage on NEXTracker (NASDAQ:NXT) with a Buy rating and announces Price Target of $40. NXT
Read More 1 minute read Analyst Ratings Initiation News Price Target Citigroup Initiates Coverage On NEXTracker with Neutral Rating, Announces Price Target of $36 By Benzinga Newsdesk March 6, 6:57 AM Citigroup analyst Ryan Levine initiates coverage on NEXTracker (NASDAQ:NXT) with a Neutral rating and announces Price Target of $36. NXT
Read More 1 minute read Analyst Ratings Initiation News Price Target Ascendiant Capital Initiates Coverage On ShiftPixy with Buy Rating, Announces Price Target of $6 By Benzinga Newsdesk March 6, 6:51 AM Ascendiant Capital analyst Lucas Ward initiates coverage on ShiftPixy (NASDAQ:PIXY) with a Buy rating and announces Price Target of $6. PIXY
Read More 1 minute read Analyst Ratings Initiation News Price Target Barclays Initiates Coverage On NEXTracker with Overweight Rating, Announces Price Target of $42 By Benzinga Newsdesk March 6, 6:43 AM Barclays analyst Christine Cho initiates coverage on NEXTracker (NASDAQ:NXT) with a Overweight rating and announces Price Target of $42. NXT
Read More 1 minute read Analyst Ratings Initiation News Price Target Piper Sandler Initiates Coverage On Chinook Therapeutics with Overweight Rating, Announces Price Target of $41 By Benzinga Newsdesk March 6, 6:38 AM Piper Sandler analyst Yasmeen Rahimi initiates coverage on Chinook Therapeutics (NASDAQ:KDNY) with a Overweight rating and announces Price Target of $41. KDNY
Read More 1 minute read Analyst Ratings Initiation News Price Target Jefferies Initiates Coverage On Bristol-Myers Squibb with Hold Rating, Announces Price Target of $62 By Benzinga Newsdesk March 6, 6:37 AM Jefferies analyst Akash Tewari initiates coverage on Bristol-Myers Squibb (NYSE:BMY) with a Hold rating and announces Price Target of $62. BMY
Read More 1 minute read Analyst Ratings Initiation News Price Target Jefferies Initiates Coverage On Pfizer with Hold Rating, Announces Price Target of $43 By Benzinga Newsdesk March 6, 6:35 AM Jefferies analyst Akash Tewari initiates coverage on Pfizer (NYSE:PFE) with a Hold rating and announces Price Target of $43. PFE
Read More 1 minute read Analyst Ratings Initiation News Keybanc Initiates Coverage On NEXTracker with Sector Weight Rating By Benzinga Newsdesk March 6, 6:00 AM Keybanc analyst Sophie Karp initiates coverage on NEXTracker (NASDAQ:NXT) with a Sector Weight rating. NXT